Navigation Links
New clinical trial explores role of vitamin D in preventing esophageal cancer
Date:10/19/2010

CLEVELAND In a first-of-its-kind clinical trial, physicians at University Hospitals (UH) Case Medical Center who are Case Western Reserve University School of Medicine researchers are exploring the role of Vitamin D in preventing esophageal cancer. Principal Investigator Linda Cummings, MD, along with Amitabh Chak, MD, and Gregory Cooper, MD, from the UH Digestive Health Institute, is recruiting patients with Barrett's esophagus to measure the effects of Vitamin D on protein levels that may influence the risk of developing esophageal cancer.

"Vitamin D is being studied for its role in possibly reducing the risk of developing several types of cancer, such as colon, breast and prostate," says Dr. Cummings, a gastroenterologist with the UH Digestive Health Institute and Assistant Professor at Case Western Reserve University School of Medicine. "This novel study is the first-of-its-kind looking at Vitamin D's potential role in helping to prevent esophageal cancer." According to co-investigator Sanford Markowitz, MD, Ingalls Professor of Cancer Genetics at Case Western Reserve University School of Medicine and oncologist with UH Case Medical Center, the study "has the potential to make a highly important contribution to the medical management of Barrett's esophagus, which is becoming an ever increasing challenge."

The study is funded by the National Institutes of Health and American College of Gastroenterology through Case Western Reserve University School of Medicine and was awarded in July.

Over the last 30 years, there has been a dramatic rise in Barrett's esophagus, a change in the lining of the esophagus that is a precursor to esophageal cancer. In this study, researchers are examining if Vitamin D intake is linked to an increase in a protein called 15-PGDH (15-prostaglandin dehydrogenase), which may help prevent Barrett's from turning into cancer. Patients with Barrett's esophagus will take Vitamin D weekly (50,000 IU) for up for
'/>"/>

Contact: Alicia Reale
alicia.reale@uhhospitals.org
216-844-5158
University Hospitals Case Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Oklahoma clinical trial to test early detection technique for eye disease in premature infants
2. Clinical trials demonstrate effective weight loss strategies for obese and overweight adults
3. U-M receives NIH, FDA grant to study adaptive clinical trial designs
4. MJFF announces over $10 million in funding for clinical and pre-clinical PD research
5. Bioethics scholars fault requirement that all women in clinical drug trials use contraception
6. Clinical trial establishes catheter-based aortic valve replacement as new standard of care
7. New TB vaccine enters clinical testing
8. Aeras and Crucell announce Phase II clinical trial start in Kenya
9. First clinical trials successfully completed on potent new hepatitis C drug
10. Conference on the Future of Independent Academic Clinical Research in Europe
11. Preclinical inquiry into 1 mutation sheds light on addiction and a birth defect
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... HealthDay Reporter , THURSDAY, Sept. 18, 2014 ... West Africa is starting to spread faster than ever, the World ... the deadly viral infection were reported in just one week. ... with roughly half of those reported in the past three weeks, ... tops 2,600. WHO has estimated that as many as 20,000 ...
(Date:9/18/2014)... It’s been just a few short weeks ... bunion splint to website visitors, but already the response has ... absolutely delighted. It is perfect and I find it sooo ... THANK YOU FOR LISTENING!!!" Another user compared the original ... used to slip to the end of my toe. Now ...
(Date:9/18/2014)... It is that time of year – time ... again, Evensong Spa at Heidel House Resort ... at a special $50 rate Oct. 20 through Nov. 1. ... & Resorts , is the only Wisconsin destination spa participating ... health and wellness by experiencing affordable spa and wellness treatments. ...
(Date:9/18/2014)... supplements of selenium or vitamin E don,t seem ... men, a new study indicates. Previous animal research ... cataracts. To investigate this further, William Christen, from Brigham ... and his colleagues examined data from a randomized, placebo-controlled ... initially designed to study prevention of prostate cancer. ...
(Date:9/18/2014)... 19, 2014 In 2003, ... Mission (Misión Barrio Adentro), which it hoped ... system (see Section 6.1.3.). In 2009, it ... Autonomous Service of Pharmaceutical Elaborations (Servicio Autónomo ... provides medicines at a cheaper rate than ...
Breaking Medicine News(10 mins):Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 2Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 3Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3Health News:Evensong Spa Celebrates Spa Week with $50 Services 2Health News:Evensong Spa Celebrates Spa Week with $50 Services 3Health News:Vitamin E, Selenium Supplements Don't Seem to Prevent Cataracts 2Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 2Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 3Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 4
... By Randy Dotinga HealthDay Reporter , TUESDAY, Sept. ... gel based on the active ingredient of the injectable Botox ... known as crow,s feet -- without the pain of needles. ... toxin, last for about four months, comparable to that produced ...
... HealthDay Reporter , TUESDAY, Sept. 20 (HealthDay News) -- Young adults ... birth much thought, but a new study finds that health problems ... some time. From 18 to 36 years of age, people ... death compared to young adults born at a normal gestational age, ...
... Reporter , TUESDAY, Sept. 20 (HealthDay News) -- Adding ... and teens with obsessive-compulsive disorder, new research shows. ... the Journal of the American Medical Association , ... obsessive-compulsive disorder (OCD). "[If] a child has ...
... against methamphetamine and nicotine have been selected to receive ... The two scientists, Dr. Thomas Kosten, of Baylor ... the University of Connecticut, Storrs, will each receive $500,000 ... according to the National Institute on Drug Abuse (NIDA), ...
... 20 (HealthDay News) -- New research finds that compared to ... diagnosis and boosted the likelihood that high-risk, underserved women who ... But there,s a big catch. Researchers were able to reduce ... -- compared to the usual $3,500 -- thanks to a ...
... of Health (NIH) has awarded nearly $2 million to ... University to develop a new class of therapeutics for ... five-year project focuses on developing biomaterials capable of capturing ... to wound sites to enhance tissue regeneration in adults. ...
Cached Medicine News:Health News:Anti-Wrinkle Gel Might Work Like Botox Without Needles 2Health News:Anti-Wrinkle Gel Might Work Like Botox Without Needles 3Health News:Problems From Preterm Birth May Return in Adulthood 2Health News:Problems From Preterm Birth May Return in Adulthood 3Health News:Adding Psychotherapy to Meds Helps Kids With OCD 2Health News:NIDA Avant-Garde-Medications Development Award winners announced 2Health News:MRI Can Spot Breast Cancer in High-Risk Women: Study 2Health News:Transformative NIH grant will support development of tissue regeneration therapeutics 2Health News:Transformative NIH grant will support development of tissue regeneration therapeutics 3
(Date:9/18/2014)... 2014  Spring Bank Pharmaceuticals, Inc., a clinical-stage ... of RNA viruses, today announced a research collaboration ... animal testing of the Company,s lead compound, SB ... Pathogens," against which currently there are no effective ... Bank,s proprietary Small Molecule Nucleic Acid Hybrid ...
(Date:9/18/2014)... 18, 2014 /CNW/ - A new expert panel report, ... , released today by the Council of Canadian ... medicines for children. Each year about half of ... least one prescription drug. Much of this prescribing is ... use), creating potential health risks. Children have ...
(Date:9/18/2014)... , Sept. 18, 2014   Auxilium Pharmaceuticals, ... specialty biopharmaceutical company, today announced the first presentation ... AUX-CC-867 MULTICORD (MULtiple Treatment Investigation of Collagenase Optimizing ... study evaluated collagenase clostridium histolyticum (CCH) for the ... same hand. In addition, the study examined expanded ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 3Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 2Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 3Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 4Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 5Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 6Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 7
... Incorporated,s (Nasdaq: VPHM ) first quarter financial results ... 28, 2011 before the open of the U.S. financial markets. ... live audio webcast at 9:00 a.m. Eastern Time on the ... the 2011 first quarter financial results and other business. ...
... LLC, through its website lawsuitssettlementfunding.com announced today ... in need of lawsuit cash advances ... leader; however they are striving to set themselves apart ... that they have ramped up their operations involving Avandia ...
Cached Medicine Technology:ViroPharma to Release 2011 First Quarter Financial Results On April 28, 2011 2Legal-Bay LLC Announces Opening of Jones Act Lawsuit Funding Division 2
Substrate Plasma for Factor V Assay by STA© Analyzers. Freeze-dried human plasma, artificially depleted of factor V....
Substrate Plasma for Factor VIII Assay by STA© Analyzers. Freeze-dried human plasma from which factor VIII has been removed by selective immuno-adsorption....
Immuno-turbidimetric Assay of von Willebrand Factor (vWF) Antigen by STA© Analyzers. Microlatex particles coated with rabbit anti-human vWF antibodies....
Colorimetric Assay of Plasminogen Activity by STA© Analyzers....
Medicine Products: